Accessibility Menu
PureTech Health Plc logo

PureTech Health Plc(NASDAQ) PRTC

Market CapN/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2020)-57%
5 Year-66%
1 Year+0%
1 Month+6%
N/A
PureTech Health Plc last closing stock price
MetricPriceDate
Last closeUSD 17.092026-08-31
PureTech Health Plc stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+10.23%USD 15.502026-08-24
1 month+5.66%USD 16.172026-07-30
3 month-4.23%USD 17.842026-06-02
Year to date+2.67%USD 16.642025-12-31
1 year+0.09%USD 17.072025-08-29
3 year-28.51%USD 23.902023-09-01
5 year-66.12%USD 50.432021-09-01
Since inception-56.65%USD 38.502020-11-16

PureTech Health Plc Financials at a Glance

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$8.96M

Net Income (TTM)

-$55.98M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Estimated Earnings Date

Aug 27, 2026

PRTC News

featured-earnings-leadership-highlights.png

PureTech Health Cash Runway Extended

Motley Fool Markets TeamSep 2, 2025

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About PureTech Health Plc

PureTech Health plc is a biotechnology company focused on developing differentiated medicines for serious diseases, including inflammatory, fibrotic, and immunological conditions. The company operates through various segments, emphasizing innovative solutions for intractable cancers and neurological disorders.

Products and Services
  • Development of therapies targeting inflammatory and fibrotic diseases
  • Innovative treatments for intractable cancers and neurological disorders
  • Focus on lymphatic and gastrointestinal disease solutions
Growth Outlook
  • Strong pipeline of therapies addressing unmet medical needs
  • Expansion into new therapeutic areas expected to drive growth
  • Strategic partnerships enhancing research and development capabilities
Financial Highlights
  • Market capitalization of approximately $384 million
  • Stock price range between $14.50 and $19.92 over the past year
  • Beta of 0.793 indicates lower volatility compared to the market
PureTech Health plc is positioned in the biotechnology sector, focusing on innovative treatments for complex diseases. The company’s diverse product offerings and strategic growth initiatives highlight its commitment to addressing significant healthcare challenges. With a solid market capitalization and a stable stock price range, PureTech Health presents an intriguing opportunity for investors interested in the biotechnology field. The company's focus on research and development, along with its strategic partnerships, is expected to drive future growth and enhance its market presence.
AI Generated • Aug 23, 2026

Industry

Biotechnology

Sector

Health Care

CEO

Robert William Henry Lyne

Website

puretechhealth.com

Headquarters

Boston, MA 02210, US

PRTC Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

N/A

Return on Capital

-29.71%

Return on Assets

N/A

Earnings Yield

N/A

Payout Ratio

N/A

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

-$17.59M

Operating Income

-$234.43M

EBITDA

-$57.61M

Operating Cash Flow

-$219.18M

Capital Expenditure

-$16.98K

Free Cash Flow

-$219.20M

Cash & ST Invst.

$278.90M

Total Debt

$19.59M

PureTech Health Plc Performance Analysis

PureTech Health Plc annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 15,608,362-10.2%
20232023-12-31USD 3,342,907-78.6%
20242024-12-31USD 4,830,03244.5%
20252025-12-31USD 4,669,887-3.3%
PureTech Health Plc sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-06-3061.3%
Q42024-12-311298.3%
Q22025-06-30-54.0%
Q42025-12-3151.1%
PureTech Health Plc annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -1.77-16.4%
20232023-12-31USD -2.3935.1%
20242024-12-31USD 2.09N/A
20252025-12-31USD -4.57N/A
PureTech Health Plc sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-06-30-99.5%
Q42024-12-31333.3%
Q22025-06-30-154.3%
Q42025-12-31-1315.8%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$2.80M

+1466.6%

Gross Profit

$1.15M

+168.4%

Gross Margin

41.03%

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

56

N/A

Net Income

-$64.89M

-60.7%

EBITDA

-$48.75M

-336.6%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Total Cash

$278.90M

-14.7%

Total Debt

$19.59M

-22.7%

Accounts Receivable

$8.13M

+242.2%

Inventory

$0.00

N/A

Long Term Debt

$11.09M

-39.2%

Short Term Debt

$8.50M

+19.8%

Return on Assets

N/A

N/A

Return on Invested Capital

N/A

N/A

Free Cash Flow

-$38.48M

+4.1%

Operating Cash Flow

-$38.47M

+3.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CLYMClimb Bio, Inc.
$13.73-5.77%
GNTAGenenta Science S.p.A.
$1.02+2.00%
INBXInhibrx Biosciences Inc.
$126.70+2.67%
IVAInventiva S.A.
$4.68-0.53%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$71.92+0.00%
WETOWetour Robotics
$5.48-0.04%
IBITiShares Bitcoin Trust
$44.67+0.02%
INTCIntel
$89.51+0.00%

Questions About PRTC

What is the current price of PureTech Health Plc?

PureTech Health Plc is trading at N/A per share.

What is the 52-week range for PureTech Health Plc?

Over the past 52 weeks, PureTech Health Plc has traded between N/A and N/A.

How much debt does PureTech Health Plc have?

As of the most recent reporting period, PureTech Health Plc reported total debt of $19.76M.

How much cash does PureTech Health Plc have on hand?

PureTech Health Plc reported $254.07M in cash and cash equivalents in its most recent financial results.

What is PureTech Health Plc’s dividend yield?

PureTech Health Plc does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services